Results 231 to 240 of about 126,067 (267)
Some of the next articles are maybe not open access.
Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety
Current Opinion in Pulmonary Medicine, 2010This article reviews findings from recently published randomized controlled trials and systematic reviews to provide an up-to-date assessment of the efficacy and safety of tiotropium, the only currently available long-acting muscarinic antagonist, when used alone or in conjunction with other respiratory medications in the treatment of chronic ...
openaire +2 more sources
Annals of Pharmacotherapy, 2013
OBJECTIVE To evaluate the efficacy and safety of aclidinium bromide, a novel, long-acting inhaled muscarinic receptor antagonist approved by the Food and Drug Administration (FDA) in July 2012, as a treatment in the management of moderate to severe chronic obstructive pulmonary disease (COPD).
J Andrew, Woods +2 more
openaire +2 more sources
OBJECTIVE To evaluate the efficacy and safety of aclidinium bromide, a novel, long-acting inhaled muscarinic receptor antagonist approved by the Food and Drug Administration (FDA) in July 2012, as a treatment in the management of moderate to severe chronic obstructive pulmonary disease (COPD).
J Andrew, Woods +2 more
openaire +2 more sources
Annals of Internal Medicine, 2011
BACKGROUND Chronic obstructive pulmonary disease (COPD), a largely preventable and manageable respiratory condition, affects an estimated 12% to 20% of adults.
A. Gershon +6 more
semanticscholar +1 more source
BACKGROUND Chronic obstructive pulmonary disease (COPD), a largely preventable and manageable respiratory condition, affects an estimated 12% to 20% of adults.
A. Gershon +6 more
semanticscholar +1 more source
[Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].
Ugeskrift for laeger, 2015Long-acting bronchodilators are central in the management of chronic obstructive pulmonary disease (COPD). This short review provides an overview of the studies evaluating the safety and efficacy of inhaled glycopyrronium, a long-acting muscarinic antagonist, in patients with COPD.
openaire +1 more source
Glycopyrronium: a new long-acting anticholinergic for maintenance treatment of COPD
Hot Topics in Respiratory Medicine, 2014Miriam Barrecheguren +2 more
openaire +1 more source
Do long-acting inhaled anticholinergics provide any benefit to an asymptomatic patient with COPD?
Evidence-Based Practice, 2021Cheryl K. Verma +2 more
openaire +1 more source
Role of long-acting anticholinergic drugs in the treatment of bronchial asthma in children
Voprosy praktičeskoj pediatrii, 2019N.G. Kolosova +2 more
openaire +1 more source